We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Earlier this year, the 2014 Royal Society Pfizer Prize was awarded to Kenyan scientist Faith Osier for her efforts to understand human immunity to malaria in endemic areas of Kenya.
The prize is given to young African scientists making outstanding contributions to the biological sciences on the continent. Last week, Osier, who works at the KEMRI-Wellcome Trust research programme in Kilifi, Kenya, gave a presentation on her work at the Royal Society in London, United Kingdom, and was awarded a visiting professorship at the University of Oxford.
In this interview, she explains to SciDev.Net how her team’s research into child and adult immunity to malaria can aid vaccine development, and about plans to carry out further related studies on immunity across seven African countries over the next five years. She also shares her thoughts on how to improve links between researchers and policymakers in East Africa, and on creating a more supportive environment for girls and women pursuing scientific careers in Kenya. 

Related topics